Increasing hdl and lowering ldl cholesterol
Pro Research Analysisby 
Searched over 200M research papers
LDL and HDL Cholesterol: Cardiovascular Risk and Treatment Focus
Lowering low-density lipoprotein cholesterol (LDL-C) is the main goal in managing dyslipidemia and reducing cardiovascular disease risk. However, even after reaching recommended LDL-C targets, many patients still experience cardiovascular events, suggesting that other lipid factors, such as high-density lipoprotein cholesterol (HDL-C), also play a role in residual risk 245. Low HDL-C and high triglycerides are recognized as independent risk factors for cardiovascular disease, especially in people with metabolic syndrome or insulin resistance 28.
Pharmacological Approaches: Statins, CETP Inhibitors, and SGLT2 Inhibitors
Statins are well-established for lowering LDL-C and reducing cardiovascular events, but their effect on raising HDL-C is modest 510. Cholesteryl ester transfer protein (CETP) inhibitors, such as anacetrapib, have shown the ability to significantly raise HDL-C (by over 100%) and lower LDL-C (by about 18%), with some evidence of reduced major coronary events . However, previous CETP inhibitors (torcetrapib, dalcetrapib, evacetrapib) did not consistently reduce cardiovascular events or mortality, and the overall benefit of raising HDL-C remains uncertain 14510.
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, primarily used for diabetes, have been found to slightly increase both LDL-C and HDL-C while lowering triglycerides. The changes are small but consistent across different drugs and populations .
Lifestyle Interventions: Exercise and Diet
Regular aerobic exercise is effective in increasing HDL-C and improving its quality and function. High-intensity exercise in particular can raise HDL-C by up to 17% and lower LDL-C by 13%, as well as improve antioxidant properties and reduce triglycerides and oxidized LDL, making lipoproteins more protective against atherosclerosis . Exercise also increases the size and function of HDL particles, which may be as important as simply raising HDL-C levels 65.
Dietary cholesterol intake has a modest effect on LDL-C, with an increase of 100 mg/day raising LDL-C by about 2–4.5 mg/dL. The effect on HDL-C is less clear: in men, higher dietary cholesterol may slightly lower HDL-C, while in women, it may slightly increase it. The clinical significance of these changes in HDL-C is still uncertain .
HDL Functionality vs. Quantity
Recent research suggests that the protective effects of HDL may depend more on its functionality—such as its ability to remove cholesterol from cells and its antioxidant properties—than on the absolute HDL-C level 510. Many drugs that raise HDL-C do not necessarily improve cardiovascular outcomes, possibly because they do not enhance HDL function 4510. Improving HDL function and raising apolipoprotein A-I, a key protein in HDL, may be more promising strategies 46.
Emerging Therapies and Future Directions
New approaches targeting triglyceride-rich lipoproteins and their metabolism, such as inhibitors of apolipoprotein C3 (APOC3) and angiopoietin-like 3 (ANGPTL3), are being studied. These agents can lower triglycerides and may also affect HDL and LDL levels, but large clinical trials are needed to confirm their benefits .
Conclusion
Lowering LDL-C remains the most proven strategy for reducing cardiovascular risk. While raising HDL-C has been a target, simply increasing HDL-C levels does not always translate to better outcomes. Lifestyle changes, especially regular exercise, can improve both HDL-C levels and function, while some medications can modestly affect both LDL-C and HDL-C. The focus is shifting toward improving HDL functionality and targeting other lipid abnormalities to further reduce cardiovascular risk 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic